The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

Omega Oil & Gas kicks off play-defining drilling campaign at Canyon-3

Omega Oil & Gas has commenced drilling operations at Canyon-3, another key step in confirming the…
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 31: Pilbara Minerals, BrainChip and 4DMedical spark fresh investor interest

Pilbara Minerals, Dateline Resources and Strike Energy top this week's most viewed stocks, while 4DMedical, Liontown…

Ariana Resources earns US$3.7M from further asset sale in Turkiye

Ariana Resources has sold its legacy 9.9% interest in the Kiziltepe Sector in Türkiye to Proccea…

Meteoric Resources unveils confidence boosting Caldeira DFS

Meteoric Resources has unveiled a DFS for its Caldeir rare earth project in Brazil which has…